Wilson Sonsini is pleased to support the LaunchBio Larger Than Life Science series, Scale-Up, Getting Your ADC Therapeutic to Market Faster. The global antibody drug conjugate market size was valued at USD 4.3 billion in 2020 and expected to see a compound annual growth rate (CAGR) of 23.7% from 2021 to 2028. With such huge market potential, investment dollars are flowing toward ADC start-ups. However, the complex process of scaling up these large molecules for the clinic can present challenges and requires significant funding. A panel of experts will focus on best practices and insights in the process that can help avoid costly pitfalls which delay therapeutics going into the clinic and eat up precious investment dollars.